Background: Combination therapy with immune checkpoint inhibitors (ICIs) has been widely used for clinical treatment in recent years, which has a better survival benefit. However, not all patients can
Background: Numerous studies have shown that infiltrating eosinophils play a key role in the tumor progression of bladder urothelial carcinoma (BLCA). However, the roles of eosinophils and associated
This article describes the case of a 73-year-old patient with grade 3 immune checkpoint inhibitor (ICI)-induced enteritis. Five different immunosuppressive agents (glucocorticoids, high-dose inflixima
acomparison vs. non-neoplastic urothelium. bp≤0.0001 vs. non-neoplastic urothelium. cp≤0.005 vs. non-neoplastic urothelium. dp<0.05. Urothelial carcinoma (UC); Standard error (SE).
